Tina E Ormstrup

Direct-access to abdominal ultrasonic investigation from general practice—the role in earlier cancer diagnosis.

P. Vedsted, Mads Lind Ingeman, Tina E Ormstrup, 2015, Family practice.

Baseline bone involvement in multiple myeloma – a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients

T. Plesner, P. Holdgaard, M. Hinge, 2016, Haematologica.

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma

T. Plesner, P. Holdgaard, N. Pallisgaard, 2020, Clinical hematology international.

Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment

T. Plesner, P. Holdgaard, M. Hinge, 2016, Haematologica.

Predicting brain metastases of breast cancer based on serum S100B and serum HER2

I. Brandslund, K. Steffensen, E. Lund, 2013, Oncology letters.

First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro

T. Plesner, J. Delaissé, K. Søe, 2010, European journal of haematology.

Cancers detected by thoracoabdominal computed tomography in patients with nonspecific symptoms.

S. Rafaelsen, M. R. Pedersen, Tina E Ormstrup, 2021, Danish Medical Journal.